Discovery Lecture Series

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.

From left, Bradley Malin, PhD, Microsoft chief scientific officer Eric Horvitz, MD, PhD, and Peter Embí, MD, MS, addressed last week’s ADVANCE symposium on health care AI. (photo by Donn Jones)

Patient voices critical to success of artificial intelligence in health care

Sponsored by the Department of Biomedical Informatics, the symposium showcased the work of the department’s center for AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence.

Eric Horvitz, MD, PhD

Microsoft’s Eric Horvitz set for next Discovery Lecture

Horvitz, an elected member of the National Academy of Engineering, is a pioneer in the applications of machine learning, AI and decision science.

(photo by Erin O. Smith)

Ramakrishnan’s Discovery Lecture

Nobel laureate Venki Ramakrishnan, PhD, center, author of Why We Die: The New Science of Aging and the Quest for Immortality, delivered the Sept. 26 Discovery Lecture.

Nobel laureate James Rothman to present on synaptic neurotransmission

Rothman, the Sterling Professor of Cell Biology at Yale University, shared the 2013 Nobel Prize in Physiology or Medicine for “discoveries of machinery regulating vesicle traffic, a major transport system in our cells.” 

Venki Ramakrishnan, PhD

Nobel laureate to speak at VUMC on the ribosome and ‘why we die’

The subject of his Discovery Lecture, which will begin at 4 p.m. Sept. 26 in 208 Light Hall, is the role of ribosomes in initiating the translation of DNA into RNA, a precursor step to transcribing the genetic code into proteins that do the work of the cell.

1 2 3 22